BIO ANNOUNCES 2001-2002 BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE
"We are extremely pleased to have industry representatives of such high caliber serve on our board," said Carl B. Feldbaum, BIO president. "Their expertise and leadership will prove invaluable to our membership as our pioneering technology continues to break new ground in finding therapies for diseases such as Parkinson's, Alzheimer's, various cancers and diabetes, as well as new solutions to improve agriculture," said Feldbaum.
Members elected to the Executive Committee include Chairman David E. Robinson, Vice Chairman for Food and Agriculture Hendrik Verfaillie, Vice Chairman for Health Care Richard F. Pops, Secretary Thomas G. Wiggans, Treasurer Duane J. Roth, and Ex-Officio former Chairman Mark Skaletsky.
Board of Directors
|
David W. Anstice Merck & Co., Inc. West Point, Pennsylvania |
* |
Walter H. Moos, Ph.D. Mitokor San Diego, California |
|
|
Frank Baldino, Jr., Ph.D. Cephalon, Inc. West Chester, Pennsylvania |
* |
James Mullen Biogen, Inc. Cambridge, Massachusetts |
|
| Terence Barnett Novartis Corporation New York, New York |
H. Stewart Parker Targeted Genetics Corporation Seattle, Washington |
||
| Ernesto Bertarelli Serono International SA Geneva, Switzerland |
Richard F. Pops Alkermes, Inc. Cambridge, Massachusetts |
||
| Simon G. Best Ardana Bioscience Ltd. Edinburgh, United Kingdom |
* | Edwin C. Quattlebaum, Ph.D. MetaMorphix, Inc. Baltimore, Maryland |
|
| Wolf-Dieter Busse, Ph.D. Bayer Corporation Berkeley, California |
Hollings Renton Onyx Pharmaceuticals, Inc. Richmond, California |
||
| * | Nancy T. Chang, Ph.D. Tanox, Inc. Houston, Texas |
Norbert G. Riedel, Ph.D. Baxter International, Inc. Roundlake, Illinois |
|
| Robert Chess Inhale Therapeutic Systems, Inc. San Carlos, California |
David E. Robinson Ligand Pharmaceuticals, Inc. San Diego, California |
||
| Ralph E. Christoffersen, Ph.D. Ribozyme Pharmaceuticals, Inc. Boulder, Colorado |
Duane J. Roth Alliance Pharmaceutical Corp. San Diego, California |
||
| * | Charles A. Fischer Dow AgroSciences Indianapolis, Indiana |
James E. Rurka Microcide Pharmaceuticals, Inc. Mountain View, California |
|
| Edward V. Fritzky Immunex Corporation Seattle, Washington Research |
John A. Ryals Paradigm Genetics Triangle Park, North Carolina |
||
| L. Patrick Gage, Ph.D. Wyeth-Ayerst Research Collegeville, Pennsylvania |
Una S. Ryan, Ph.D. AVANT Immunotherapeutics, Inc. Needham, Massachusetts |
||
| * | Donal J. Geaney Elan Corporation, plc. Dublin, Ireland |
* | Edward T. Shonsey Syngenta Seeds, Inc. Golden Valley, Minnesota |
| * | William A. Haseltine, Ph.D. Human Genome Sciences, Inc. Rockville, Maryland |
Mark Skaletsky The Althexis Co., Inc. Waltham, Massachusetts |
|
| Wayne T. Hockmeyer, Ph.D. MedImmune, Inc. Gaithersburg, Maryland |
Frederick W. Telling, Ph.D. Pfizer, Inc. New York, New York |
||
| David P. Holveck Centocor, Inc. Malvern, Pennsylvania |
Henri A. Termeer Genzyme Corporation Cambridge, Massachuetts |
||
| Vaughn M. Kailian COR Therapeutics, Inc. South San Francisco, California |
Hendrik Verfaillie Monsanto Company St. Louis, Missouri |
||
| Louis G. Lange, M.D., Ph.D. CV Therapeutics, Inc. Palo Alto, California |
John P. Walker Axys Pharmaceuticals, Inc. Atherton, California |
||
| Edward Lanphier Sangamo BioSciences, Inc. Richmond, California |
Roy A. Whitfield Incyte Genomics, Inc. Palo Alto, California |
||
| Benjamin F. McGraw, Ph.D. Valentis, Inc. Burlingame, California |
Thomas G. Wiggans Connetics Corporation Palo Alto, California |
||
| Alex McPherson, M.D., Ph.D. Biomira, Inc. Edmonton, Alberta, Canada |
* Indicates new board member
BIO represents more than 1000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products.